Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record.

PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009

Jourde‐Chiche, Noémie, Dou, Laetitia, Cerini, Claire, Dignat‐George, Françoise, Vanholder, Raymond, Brunet, Philippe·2009·Seminars in Dialysis

Abstract

Protein‐bound uremic retention solutes constitute a group whose common characteristic is their difficult removal by dialysis. In 2003, the EUTox group described 25 protein‐bound solutes. They comprised six advanced glycation end products (AGE), four phenols (including p‐cresol), six indoles (including indoxylsulfate), two hippurates, three polyamines, and two peptides, homocysteine and 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropionic acid (CMPF). As then, three new compounds have been added to the list: phenylacetic acid, dinucleoside polyphosphates, and IL‐18. During the last years, protein‐bound compounds have been identified as some of the main toxins involved in vascular lesions of chronic kidney disease. The removal of these solutes by conventional hemodialysis (HD) is low because only the free fraction of the solute is available for diffusion. The increase in the convective part with hemodiafiltration improves the performance of depuration but convection only applies to the free fraction and its benefit is limited. One possibility to improve the removal of a protein‐bound solute would be to stimulate its dissociation from the binding protein. This could be obtained in experiments by setting the dialysate flow rate and the dialyzer mass transfer area coefficient (KoA) at much higher levels than the plasma flow rate, or by adding to the dialysate a sorbent such as activated charcoal or albumin. In the future, specific adsorbents may be developed. Today, the only possibility is to use approaches such as daily HD and long HD which could allow better equilibration between extravascular and vascular compartments and consequently result in greater removal of protein‐bound compounds.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1525-139x.2009.00576.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 49

  1. 10.1046/j.1523-1755.2003.00924.x · DOI · Paper page
  2. 10.1007/s00467-008-0762-9 · doi:10.1007/s00467-008-0762-9
  3. 10.1046/j.1523-1755.2001.07805.x · DOI
  4. 10.1053/j.arrt.2003.08.002 · DOI
  5. 10.1681/ASN.2005030310 · DOI · Paper page
  6. 10.1093/ndt/gfl584 · DOI · Paper page
  7. 10.1038/ki.2008.31 · DOI · Paper page
  8. 10.1038/sj.ki.5000115 · DOI · Paper page
  9. Jankowski J, 1998, Characterization of dimethylguanosine, phenylethylamine, and phenylacetic acid asinhibitors of Ca2+ ATPase in end‐stage renal failure, J Am Soc Nephrol, 9, 1249, 10.1681/ASN.V971249 · DOI
  10. 10.1172/JCI200315524 · DOI
  11. 10.1093/ndt/gfn266 · DOI
  12. 10.1093/ndt/gfm475 · DOI
  13. 10.1093/ndt/gfm455 · DOI
  14. 10.1080/10408440701638970 · DOI · Paper page
  15. 10.1007/s00726-006-0264-7 · DOI
  16. 10.1111/j.1744-9987.2006.00370.x · DOI
  17. 10.1211/0022357001774372 · DOI
  18. 10.1111/j.1523-1755.2004.00399.x · DOI · Paper page
  19. 10.1046/j.1523-1755.2001.07850.x · doi:10.1046/j.1523-1755.2001.07850.x
  20. Pawlak D, 2003, Kynurenine and its metabolites in the rat with experimental renal insufficiency, J Physiol Pharmacol, 54, 175
  21. 10.1042/BST0351287 · DOI
  22. 10.1007/s10571-006-9124-y · DOI
  23. Karasek M, 2005, Decreased melatonin nocturnal concentrations in hemodialyzed patients, Neuro Endocrinol Lett, 26, 653
  24. 10.1034/j.1600-079X.2001.310305.x · DOI
  25. 10.1159/000186729 · doi:10.1159/000186729
  26. Kancheva R, 2008, Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy: a pilot study, Physiol Res, 57, S181, 10.33549/physiolres.931503 · doi:10.33549/physiolres.931503
  27. 10.1097/MNH.0b013e32830f45b6 · DOI
  28. 10.1093/ndt/gfm861 · DOI · Paper page
  29. 10.1111/j.1538-7836.2007.02540.x · DOI · Paper page
  30. 10.1111/j.1538-7836.2005.01780.x · DOI · Paper page
  31. 10.1046/j.1523-1755.2003.00906.x · DOI · Paper page
  32. 10.1080/08860220802356531 · DOI
  33. 10.1159/000074327 · DOI
  34. 10.1111/j.1365-2362.2004.01418.x · DOI
  35. 10.1093/ndt/gfn098 · doi:10.1093/ndt/gfn098
  36. 10.1111/j.1525-139X.2009.00585.x · DOI
  37. 10.1111/j.1525-139X.2009.00579.x · DOI
  38. 10.1111/j.1525-139X.2009.00589.x · DOI
  39. 10.1053/j.ajkd.2007.12.035 · DOI
  40. 10.1111/j.1523-1755.2000.00398.x · DOI
  41. 10.1080/15216540500404093 · DOI · Paper page
  42. 10.1093/ndt/15.1.50 · doi:10.1093/ndt/15.1.50
  43. 10.1053/j.ajkd.2004.04.033 · doi:10.1053/j.ajkd.2004.04.033
  44. 10.1093/ndt/gfn522 · doi:10.1093/ndt/gfn522
  45. 10.1681/ASN.2006080863 · DOI
  46. 10.1016/j.jbiotec.2005.11.009 · doi:10.1016/j.jbiotec.2005.11.009
  47. 10.1093/ndt/gfg054 · DOI
  48. 10.1038/sj.ki.5001640 · DOI
  49. 10.1038/ncpneph1023 · doi:10.1038/ncpneph1023

Cited by

See all 159

Metadata

Authors
Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P.
Venue
Seminars in Dialysis
Publisher
Wiley
Published
2009-07
Volume
22
Issue
4
Pages
334-339
ISSN
  • 0894-0959 (ISSN-L)
  • 1525-139X
OpenAlex
W1827522486
Cited by
159
References
0
FWCI
9.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009. https://app.cochat.ai/papers/10.1111/j.1525-139x.2009.00576.x
The paper
Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P. (2009). PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009. Seminars in Dialysis. https://doi.org/10.1111/j.1525-139x.2009.00576.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.